Avadel Pharmaceuticals Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR), Edgewise Therapeutics (EWTX) and Avadel Pharmaceuticals (AVDL)
UBS Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $14
A Quick Look at Today's Ratings for Avadel Pharmaceuticals(AVDL.US), With a Forecast Between $13 to $22
Avadel Pharmaceuticals Is Maintained at Overweight by Piper Sandler
Piper Sandler Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $13
Piper Sandler Keeps Their Buy Rating on Avadel Pharmaceuticals (AVDL)
H.C. Wainwright Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $21
Avadel Pharmaceuticals Analyst Ratings
Analysts Conflicted on These Healthcare Names: Avadel Pharmaceuticals (AVDL) and ACADIA Pharmaceuticals (ACAD)
Needham Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $19
UBS Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $22
Craig-Hallum Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating
Avadel Pharmaceuticals Analyst Ratings
H.C. Wainwright Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $25
Craig-Hallum Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating
Avadel Pharmaceuticals Price Target Maintained With a $22.00/Share by Needham
Avadel Pharmaceuticals Analyst Ratings
Craig-Hallum Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating
Avadel Pharmaceuticals Is Maintained at Outperform by Oppenheimer